Cognition Therapeutics' Cash Burn and Future Prospects

Cognition Therapeutics' cash runway is 16 months, with a cash balance of $39m and a trailing 12-month cash burn of $30m. However, the company's true cash runway may be shorter if its cash burn rate continues to increase. Despite this, Cognition Therapeutics has a solid cash runway, and investors should consider whether the company will spend its cash wisely.